Elevance Health Inc.
NYSE:ELV
395.76 (USD) • At close July 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 176,810 | 171,340 | 156,595 | 138,639 | 121,867 | 104,213 | 92,105 | 90,039.4 | 84,978.4 | 79,239.9 | 73,923.1 | 71,122.4 | 61,535 | 60,804 | 58,841.2 | 61,644.3 | 62,459 | 61,394 | 57,009.2 | 45,150.8 | 20,815.9 | 16,771.4 | 13,282.3 | 10,444.7 | 17,314.5 | 12,350.7 | 11,072.1 |
| Cost of Revenue
| 19,549 | 124,330 | 116,642 | 102,645 | 88,045 | 81,786 | 71,895 | 72,236.2 | 66,834.4 | 61,116.9 | 56,854.9 | 56,237.1 | 48,213.6 | 47,647.5 | 44,926.9 | 46,990.1 | 48,210.9 | 46,436.3 | 42,520 | 33,507.9 | 15,482.8 | 14,371.6 | 11,512.5 | 19,779 | 34,177 | 24,611.6 | 21,799.4 |
| Gross Profit
| 157,261 | 47,010 | 39,953 | 35,994 | 33,822 | 22,427 | 20,210 | 17,803.2 | 18,144 | 18,123 | 17,068.2 | 14,885.3 | 13,321.4 | 13,156.5 | 13,914.3 | 14,654.2 | 14,248.1 | 14,957.7 | 14,489.2 | 11,642.9 | 5,333.1 | 2,399.8 | 1,769.8 | -9,334.3 | -16,862.5 | -12,260.9 | -10,727.3 |
| Gross Profit Ratio
| 0.889 | 0.274 | 0.255 | 0.26 | 0.278 | 0.215 | 0.219 | 0.198 | 0.214 | 0.229 | 0.231 | 0.209 | 0.216 | 0.216 | 0.236 | 0.238 | 0.228 | 0.244 | 0.254 | 0.258 | 0.256 | 0.143 | 0.133 | -0.894 | -0.974 | -0.993 | -0.969 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,109.6 | 2,506.6 | 1,986.1 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| -148,881 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,477.7 | 3,109.6 | 2,506.6 | 1,986.1 | 0 | 0 | 0 |
| Other Expenses
| 168,906 | 38,265 | 31,502 | 27,048 | 26,111 | 15,694 | 14,373 | 12,818 | 12,724.9 | 12,764.9 | 11,969.3 | 10,198.2 | 8,913.5 | 8,675 | 9,081.1 | 9,711.6 | 9,287.5 | 9,003 | 9,126.2 | 7,511.1 | 61.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 20,025 | 38,265 | 31,502 | 27,048 | 26,111 | 15,694 | 14,373 | 12,818 | 12,724.9 | 12,764.9 | 11,969.3 | 10,198.2 | 8,913.5 | 8,675 | 9,081.1 | 9,711.6 | 9,287.5 | 9,003 | 9,126.2 | 7,511.1 | 3,539.1 | 1,180.7 | 962.2 | -9,858.9 | -17,088.5 | -12,305.8 | -10,899.7 |
| Operating Income
| 7,904 | 8,745 | 8,451 | 8,946 | 7,711 | 6,733 | 5,837 | 4,985.2 | 5,419.1 | 5,358.1 | 5,098.9 | 4,687.1 | 4,407.9 | 4,481.5 | 4,833.2 | 4,942.6 | 4,960.6 | 5,954.7 | 5,363 | 4,131.8 | 1,794 | 1,219.1 | 807.6 | 524.6 | 17,314.5 | 12,350.7 | 11,072.1 |
| Operating Income Ratio
| 0.045 | 0.051 | 0.054 | 0.065 | 0.063 | 0.065 | 0.063 | 0.055 | 0.064 | 0.068 | 0.069 | 0.066 | 0.072 | 0.074 | 0.082 | 0.08 | 0.079 | 0.097 | 0.094 | 0.092 | 0.086 | 0.073 | 0.061 | 0.05 | 1 | 1 | 1 |
| Total Other Income Expenses Net
| 0 | -1,030 | -851 | -1,021 | -1,473 | -748 | -769 | -1,021.4 | -863.7 | -727.1 | -730.8 | -846.9 | -549.6 | -523.6 | -479.4 | 2,460.4 | -1,838.2 | -696.8 | -448.6 | -241.5 | -350.7 | 775.9 | 0 | 524.6 | 0 | 0 | 0 |
| Income Before Tax
| 7,904 | 7,715 | 7,600 | 7,925 | 6,238 | 5,985 | 5,068 | 3,963.8 | 4,555.4 | 4,631 | 4,368.1 | 3,840.2 | 3,858.3 | 3,957.9 | 4,353.8 | 7,403 | 3,122.4 | 5,257.9 | 4,914.4 | 3,890.3 | 1,443.3 | 1,219.1 | 807.6 | 524.6 | 0 | 0 | 0 |
| Income Before Tax Ratio
| 0.045 | 0.045 | 0.049 | 0.057 | 0.051 | 0.057 | 0.055 | 0.044 | 0.054 | 0.058 | 0.059 | 0.054 | 0.063 | 0.065 | 0.074 | 0.12 | 0.05 | 0.086 | 0.086 | 0.086 | 0.069 | 0.073 | 0.061 | 0.05 | 0 | 0 | 0 |
| Income Tax Expense
| 1,933 | 1,724 | 1,712 | 1,830 | 1,666 | 1,178 | 1,318 | 121 | 2,085.6 | 2,071 | 1,808 | 1,205.9 | 1,207.3 | 1,311.2 | 1,466.7 | 2,657.1 | 631.7 | 1,912.5 | 1,819.5 | 1,426.5 | 483.2 | 440.1 | 255.2 | 183.4 | -226 | -44.9 | -172.4 |
| Net Income
| 5,980 | 5,987 | 5,894 | 6,104 | 4,572 | 4,807 | 3,750 | 3,842.8 | 2,469.8 | 2,560 | 2,569.7 | 2,654.2 | 2,655.5 | 2,646.7 | 2,887.1 | 4,745.9 | 2,490.7 | 3,345.4 | 3,094.9 | 2,463.8 | 960.1 | 774.3 | 549.1 | 342.2 | 226 | 44.9 | 172.4 |
| Net Income Ratio
| 0.034 | 0.035 | 0.038 | 0.044 | 0.038 | 0.046 | 0.041 | 0.043 | 0.029 | 0.032 | 0.035 | 0.037 | 0.043 | 0.044 | 0.049 | 0.077 | 0.04 | 0.054 | 0.054 | 0.055 | 0.046 | 0.046 | 0.041 | 0.033 | 0.013 | 0.004 | 0.016 |
| EPS
| 26.29 | 25.69 | 24.558 | 25.037 | 18.23 | 18.814 | 14.529 | 14.695 | 9.395 | 9.734 | 9.314 | 8.892 | 8.26 | 7.348 | 7.03 | 9.96 | 4.79 | 5.64 | 4.93 | 4.03 | 3.145 | 2.8 | 2.31 | 1.66 | 1.1 | 0.22 | 0.84 |
| EPS Diluted
| 25.68 | 25.22 | 24.275 | 24.733 | 17.979 | 18.467 | 14.194 | 14.35 | 9.212 | 9.381 | 8.954 | 8.737 | 8.176 | 7.249 | 6.94 | 9.88 | 4.76 | 5.56 | 4.82 | 3.94 | 3.05 | 2.73 | 2.26 | 1.65 | 1.1 | 0.22 | 0.84 |
| EBITDA
| 9,089 | 10,490 | 10,126 | 6,004 | 8,176 | 7,216 | 6,303 | 4,981.9 | 5,574.7 | 5,619.9 | 5,296.2 | 4,796.1 | 4,710.2 | 4,723.3 | 5,117.5 | 8,408 | 4,174.8 | 6,252.6 | 5,874.6 | 4,584.5 | 1,854.7 | 1,595.3 | 255.5 | 645.1 | 17,314.5 | 12,350.7 | 11,072.1 |
| EBITDA Ratio
| 0.051 | 0.061 | 0.065 | 0.043 | 0.067 | 0.069 | 0.068 | 0.055 | 0.066 | 0.071 | 0.072 | 0.067 | 0.077 | 0.078 | 0.087 | 0.136 | 0.067 | 0.102 | 0.103 | 0.102 | 0.089 | 0.095 | 0.019 | 0.062 | 1 | 1 | 1 |